Skip to main content
FinSpry Logo
FinSpry
VYGR logo
VYGR
(NASDAQ)
Voyager Therapeutics, Inc.
$3.27-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Voyager Therapeutics (VYGR) Stock Price & Financial Analysis

Voyager Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.14 - $3.29
52-Week High$5.55
52-Week Low$2.94
Open$3.22
Volume305.57K
Average Volume (3M)658.33K
Market Cap190.39M
Shares Outstanding59.50M
Price to Sales (P/S)5.33
Price to Book (P/B)1.12
EV/EBITDA-1.54
Revenue (TTM)36.49M
Net Income (TTM)-116.64M
Free Cash Flow (TTM)-129.94M
EPS (TTM)$-1.98
Profit Margin-319.61%
Operating Margin-349.16%
Return on Equity (ROE)-67.16%
Debt to Equity0.20
50-Day MA$3.39
200-Day MA$3.87
52-Week Change4.14%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Voyager Therapeutics

What is the current stock price for VYGR?

As of the latest trading session, VYGR stock trades at $3.27. The 52-week range is $2.94–$5.55, with a day range of $3.13–$3.29.

What is the P/E ratio for VYGR?

The P/E ratio (Price-to-Earnings) for VYGR is shown in the Key Statistics section. This valuation metric helps compare Voyager Therapeutics, Inc. to industry peers.

Does VYGR pay dividends?

Voyager Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for VYGR?

Based on 5 analysts, the consensus for VYGR is Buy.

What is the market cap of VYGR?

Voyager Therapeutics's market capitalization is $194.6M, classifying it as a micro-cap company. Voyager Therapeutics operates in the Healthcare sector within the Biotechnology industry.